P&G Beats on Earnings as Tide and Febreze Lift Sales 4% to $23.3 Billion

Procter & Gamble earned $2.00 per share on an adjusted basis in its fiscal first quarter, beating the $1.88 analysts expected, as net sales rose 4% to $23.3 billion — ahead of Wall Street's $22.8 billion forecast. Shares climbed more than 2% in premarket trading Thursday.

The numbers, measured against a survey of analysts by LSEG, mark a strong opening quarter for the consumer giant's new fiscal year. The question for investors was whether shoppers, stretched and hunting value, would keep buying. This quarter, they did — mostly.

What drove the beat?

Volume grew 2.4% companywide, P&G reported. That's a notable result for a company that has watched demand soften as consumers turn more value-conscious. Executives have previously said shoppers are now using every last drop of shampoo or laundry detergent, and that value packs have grown more popular. In fiscal 2026, P&G posted volume growth in just one quarter.

Net income attributable to the company came in at $4.73 billion, or $1.97 per share, down slightly from $4.75 billion, or $1.95 per share, a year earlier. Excluding restructuring costs and other items, earnings landed at $2.00 per share. So the profit line held nearly flat while the top line grew — pricing and mix, not cost blowouts, carried the quarter.

In short: P&G sold more stuff this quarter than it has in a while.

Which brands performed?

Fabric and home care led the portfolio. The segment, which includes Tide detergent and Febreze, posted volume growth of 4.3% — nearly double the companywide pace.

Two other divisions cleared the 2% volume-growth mark:

• Baby, feminine and family care: volume up more than 2%
• Beauty: volume up more than 2%

Grooming, home to Gillette and Venus razors, slipped 0.4% in volume.

Health care was the clear laggard. Segment volume fell 2.9% as demand shrank for oral care products like Crest toothpaste and personal health items like Pepto-Bismol. One weak division inside a five-segment portfolio isn't a crisis, but it's the piece management will have to explain on the next call.

What did P&G say about guidance?

The company reiterated its fiscal 2027 forecast for core earnings per share of $6.89 to $7.11. CEO Shailesh Jejurikar said P&G is on track to meet its guidance even as it braces for continued pressure.

The company is expecting continued "geopolitical and economic challenges," Jejurikar said in a statement.

P&G did raise one number. It now projects all-in sales growth of 2% to 4% for fiscal 2027, up from its prior outlook of 1% to 3%. The bump reflects the acquisition of vitamin company Thorne, which closed on Oct. 1.

Why does this quarter matter?

A 2.4% volume gain reverses, at least for one quarter, the demand slump that defined P&G's prior fiscal year — when only a single quarter posted volume growth. Household staples like Tide did the heavy lifting, which suggests consumers are still spending on essentials even as they squeeze the last drops from the bottle. The raised sales outlook adds a new growth engine in Thorne, but the health care segment's 2.9% volume decline shows where demand remains fragile. The next few quarters will show whether this is a rebound or a one-quarter reprieve.